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The  reports  by  Bielschowksy et  al.  in  1959  (1)  on  the  natural  history  of 
autoimmune disease in NZB mice and by Helyer and Howie in  1963 (2) on the 
autoimmune disease with systemic lupus erythematosus-like glomerulonephritis 
in the (NZB ×  NZW)F~ hybrid provided the foundation for extensive studies on 
genetic,  immunologic,  and  virologic  factors  in  the  pathogenesis  of systemic 
murine  lupus  (3,  4).  Although  subsequent  studies  have  documented  multiple 
functional  and  phenotypic abnormalities  of NZB T  and  B  lymphocytes (5-8), 
only a few independently segregating loci have been identified that influence the 
expression of each of these abnormalities (5, 9-14) and only one gene has been 
assigned to a chromosomal location (15). 
The opportunity to study the effects of single genes on autoimmune disease 
has been provided by the development of mouse strains bearing the unmapped 
autosomal recessive mutation lymphoproliferation (Ipr) (16-17) and the Y chro- 
mosome-linked autoimmune  acceleration factor (Yaa) of strain  BXSB/Mp (17- 
18).  Mice homozygous for the lpr mutation or BXSB male mice develop massive 
lymphadenopathy,  immune  complex  glomerulonephritis,  hypergamma- 
globulinemia,  and autoantibodies (16-18) and have been the models of choice 
for studies of autoimmunity in many laboratories (9,  11,  12,  19, 20). 
A new spontaneous autosomal recessive mutation that occurred in the inbred 
mouse strain  C3H/HeJ determines the development of an early onset lympho- 
proliferative  disorder  with  autoimmunity  (21).  This  new  mutation  has  been 
named  generalized  /ymphoproliferative  disease,  gene  symbol gld.  Data  on  its 
natural history and basic immunopathology are reported here. This new single- 
gene model for autoimmune disease may help identify critical immunoregulatory 
pathways  and  common  pathogenetic  mechanisms  of generalized  autoimmune 
disease in mouse and man. 
Materials and Methods 
Mice.  Inbred and mutant strains C3H/HeJ-gld/gld,  C3H/HeJ-+/+, MRL/Mp-lpr/lpr, 
C3H/HeJ-lpr/lpr,  BXSB/Mp, NZB/BINJ, C56BL/6J, and SJL/J were bred and maintained 
in the authors' research colony. All mice were fed a diet of Old Guilford 96 pelleted feed 
(Emory Morse Co., Guilford, CT) and received chlorinated water ad libitum. 
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Genetics.  The specific crosses used to localize the gld mutation to chromosome 1 are 
given in  Results.  Segregating loci included the skeletal mutation Lp (loop tail)  and two 
isozyme loci,  Idh-1 (isocitrate dehydrogenase-1) and Pep-3 (peptidase-3, formerly called 
dipeptidase-3, Dip-3). The tissue used to determine Idh-1 and Pep-3 was kidney.  Single 
kidneys were homogenized in 0.5 ml distilled water and the lysate centrifuged at 27,700 
g  for  30  min.  The resulting  supernatants  were applied directly to  Titan  III cellulose 
acetate plates (Helena Laboratories, Beaumont, TX) and electrophoresis was conducted, 
cathode to anode, at 200 V for 30 min in a pH 8.5 Tris-glycine buffer. Staining for IDH- 
1 was accomplished essentially as described by Harris and Hopkinson (22).  Staining for 
PEP-3 was accomplished as described in Eppig and Eicher (23). 
Lifespan Study.  All mice were examined weekly by palpation beginning at 6 wk of age. 
Mice were autopsied when moribund. Prior to autopsy, mice were exsanguinated via the 
retroorbital sinus. Erythrocyte and leukocyte counts were determined using a Coulter cell 
counter (Coulter Electronics, Inc., Hialeah, FL). Differential leukocyte counts were based 
on examination of 200 cells per Giemsa-stained blood smear. Packed erythrocyte hema- 
tocrits  (HCT)  were  determined.  Serum  was  processed and  stored  at  -60°C  for later 
analysis. 
Cross-Sectional Study.  Groups  of five  or  six  male gld/gld  mice  were  killed  at  4-wk 
intervals spanning 4-24 wk of age and at 30,  38, and 47 wk of age. Similar numbers of 
female gld]gld and of male and female congeneic +/+ controls were examined at 8,  16, 
24, and 47 wk of age. Peripheral blood counts, including differential leukocyte analyses, 
were determined. Serum was processed as above and assayed for antinuclear antibodies 
(ANA), ~ anti-double-stranded  DNA (dsDNA),  thymocyte-binding autoantibody (TBA), 
serum  proteins,  and  immunoglobulin.  Representative  lymph  nodes  (mesenteric  node 
complex, axillary, renal, and  lumbar/caudal) were dissected,  trimmed of extracapsular 
connective tissue, and weighed. The spleen and thymus were weighed. These organs as 
well as the liver, kidneys, mediastinal mass, and salivary glands, were fixed in  Fekete's 
formol-acetic-alcohol, embedded in paraffin, sectioned at 8 #m, and stained with hema- 
toxylin and eosin (HE) for histological analysis. Sections of kidney were also stained with 
PAS/Schiff reagent. 
Lymphocyte Subset Analysis.  T  and B cells were enumerated by fluorescence microscopy 
(24)  and  by  flow  microfluorometry (FMF)  (25).  In  general,  a  pair  of suspensions  of 
mesenteric lymph node  cells  were  prepared  using  Hank's solution  containing  10  mM 
Hepes,  5%  fetal  bovine serum,  and  0.1%  sodium azide,  pH  7.2.  One  suspension  was 
exposed to a  1:2  dilution of anti-Thy-l.2 antiserum.  Both conventional allogeneic and 
monoclonal anti-Thy-1.2 (cell culture supernatant from hybridoma HO-13-4.9 [26]) were 
used.  The  duplicate  suspension  was  incubated  with  normal  mouse  serum  (NMS).  All 
suspensions were washed and  exposed to a  1:10  dilution  of fluorescein isothiocyanate 
(FITC)-conjugated goat anti-mouse immunoglobulin (FITC-GAMG) IgA +  IgG +  IgM, 
purchased from Cappel Laboratories, Cochranville, PA. The cells were again washed and 
then fixed in cold electron microscopy grade 2% formaldehyde solution. In microscopic 
analyses, 300  cells  per suspension were scored as either dead, fluorescence positive, or 
negative.  FMF  analyses were  conducted  using  an  Ortho  model  50H  cytofluorograph 
(Ortho Diagnostic Systems, Inc., Westwood, MA). Data were registered in 512 channels 
from 50,000 cells using linear or logarithmi  c amplification. 
Serum Proteins and Immunoglobulin.  Total  serum protein  was determined  by refrac- 
tometry (27)  using a  temperature-compensated TS meter (American  Optical Scientific 
Instruments, Buffalo, NY).  Serum was applied to Titan III cellulose acetate plates and 
electrophoresed for 20 min at  180  V  in a  0.05  M Tris-barbital/sodium barbital buffer 
(pH 8.8).  Each plate was stained with Ponceau S, destained, and rendered transparent. 
Serum protein electrophoretic profiles were produced on a Helena Autoscan Densitom- 
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eter/Integrator (Helena Laboratories, Beaumont, TX). 
Quantitation of the immunoglobulin classes IgA, IgG1, IgG2a, IgG2b, and IgM was 
performed by agar-gel radial immunodiffusion (RID) using prepared 24-well plates from 
Meloy Laboratories, Inc., Springfield, VA. 4 #1 of undiluted serum from 10 gld/gld and 
8 control male and female mice, 20-24 wk of age, were applied in duplicate to RID plates. 
Precipitin rings were measured 48 h later. Ig levels were determined from concurrently 
prepared standard curves. 
Analysis of Autoantibodies.  Sera were tested for ANA by indirect immunofluorescence 
using acetone-fixed frozen sections of rat  liver as the  target  substrate  (28).  The liver 
sections were overlaid with 75 #1 of individual serum samples diluted to 1:10 (routinely) 
or doubling dilutions from 1:50 to 1:1,600 (for selected sera). After an incubation of 30 
min  at  room  temperature,  the  sections  were  washed with  two changes  of phosphate- 
buffered saline (pH 7.2) and overlaid with 100 #1 of a 1:10 dilution of fluorescein-labeled 
IgG fraction of rabbit anti-mouse IgG (heavy and light chains) (FITC-RAMG). Before 
use,  the  FITC-labeled  reagent  was  absorbed  with  mouse  acetone  liver  powder  and 
ultracentrifuged. 
Selected sera were also evaluated for reactivity against native DNA using the kinetoplast 
of Crithidea luciliae (CL) (29).  Prepared CL substrate slides  were obtained from Meloy 
Laboratories, Inc. Indirect immunofluorescence techniques were used as described above. 
The intensity of fluorescence of liver nuclei or CL kinetoplast was scored as follows: 
(-), no specific fluorescence; (+), questionable; (+), weak but definite; (++), moderate; 
(+++), strong. Sera that scored ++ or greater were considered positive. 
Analyses  for TBA  were performed by  indirect immunofluorescence microscopy as 
described for lymphocyte subset analyses. Thymocytes obtained from 4-6-wk-old C3H/ 
HeJ +/+ mice were incubated first with 1:2 dilutions of individual serum samples followed 
by !: 10 diluted FITC-GAMG. 
Statistical Analyses.  All measures of variance are reported as standard errors of the 
mean (except in Table I where the standard deviation is used). Tests of significance for 
differences between independent means were performed by Student's t test. 
Results 
Genetics.  Linkage to Pep-3 (peptidase-3) was first noted in a backcross involving 
(C57BL/6By × C3H/HeJ-gld)F1 mice mated to C3H/HeJ-gld mice. Out of a total 
of 196 mice analyzed,  170 inherited a parental combination of the Pep-3 and gld 
alleles  from  their  F1  parent  (93  Pep-3"+,  77  Pep-3  b gld)  and  26  inherited  a 
recombinant combination (18 Pep-3  ~ gld, 8 Pep-3b+), indicating gld  was located 
on chromosome 1 with  13.3 ___ 9.4% recombination between it and Pep-3. 
To determine the order of gld relative to other chromosome  1 genes,  three 
other crosses were made.  In cross  1,  C57BL/6Ks females were mated to C3H/ 
HeJ-gld males and the resulting (Idh-1 b Pep-Y'+/Idh-1 ~ Pep-3  b  gld)F1 females were 
backcrossed to C3H/HeJ-gld  males.  In cross 2, a  recombinant male (Pep-3  ~ gld/ 
Pep-3  b gld) from cross  1 was mated to a Lp/+ female. Offspring that were Lp/+ 
and carried the Pep-Y' allele (ie., Pep-Y' gld+/Pep-3b+  Lp) were mated to C3H/ 
HeJ-gld/gld  mice and  the offspring classified for the  three segregating  loci.  In 
cross 3  several Pep-3"+ Lp/Pep-3 b gld+ males from cross 2  were mated to C3H/ 
HeJ-gld/gld  females and the offspring analyzed. The results of these three crosses 
are  presented  in  Table  I.  We  conclude  that gld  is  located  on  chromosome  1 
between the genes Pep-3 and Lp. 
Lifespan Analysis.  24 male and 25 female C3H/HeJ-gld/gld  and 25 female +/ 
+  control mice were held for lifespan studies.  Enlarged peripheral lymph nodes 
were readily palpable in gld homozygotes of both sexes by 13 wk of age. Enlarged 
abdominal  lymph nodes and splenomegaly were evident shortly thereafter. An GENERALIZED  LYMPHOPROLIFERATIVE  DISEASE  1N  MICE 
TABLE  I 
Analysis of Chromosomal Linkage of the gld Mutation 
ldh-l~PeP-Y'  + F 
Cross 1  idh_l,,Pep_3bgld  , 9. x  Idh-l"Pep-3bgldd(C3H-gld) 
Chromosome inherited 
from F~ parent  Region of recombi-  Total offspring  nation 
Idh- 1  Pep-3  gld 
a  b  gld  None  61 
b  a  +  54 
a  a  +  25 
b  b  gld  ldh-l-Pep-3  30 
a  b  +  13 
b  a  gld  Pep-3-gld  10 
b  b  +  ldh-l-Pep-3  1 
a  a  gld  Pep-3-gld  6 
Gene order:*  Idh-l-31.O +_ 3.3-Pep-3-15.0  +. 2.5-gld  200 Total 
Pep-Mgld + 
Cross 2  Pep-3 gld + (C3H-gld)  X Pep_3b + Lp 
Chromosome inherited from 
heterozygous parent* 
Pep-3  gld  Lp 
Region of recombi- 
nation  Total offspring 
a  gld  +  None  39 
b  +  Lp  35 
a  +  Lp  Pep-3-gld  9 
b  gld  +  3 
a  gld  Lp  gld-Lp  10 
b  +  +  4 
Gene order:  Pep-3-12.0  + 3.2-gld-14.0  + 3.5-Lp  100 Total 
9 X Pep-Y'  + Lp d 
Cross 3  Pep-3~gld  + (C3H-gld)  Pep_3bgld  + 
Chromosome inherited from 
heterozygous parent 
Pep-3  gld  Lp 
a  +  Lp 
b  gld  + 
Region of recombi- 
nation 
None 
Total offspring 
43 
35 
a  gld  +  Pep-3-gld  12 
b  +  Lp  3 
a  +  +  2 
b  gld  Lp  gld-Lp  3 
Gene order:  Pep-3-15.3  +- 3.6-gld-5.1  + 2.2-Lp  98 Total 
* Percent recombination -+ SD. 
* Data combined from heterozygous female and male parents. ROTHS,  MURPHY,  AND  EICHER  5 
episode of marked regression of lymph node enlargement was observed during 
subsequent periodic inspections (documented in  detail  in a  separate  cross-sec- 
tional study described below).  Both male and  female gld/gld  mice have a  pro- 
tracted clinical course and survive to a  mean age of 396 +  13 and 368 +_ 18 d, 
respectively (not significantly different by t test analysis). The longevity of female 
+/+ control mice was nearly double (688 +__ 35 d) that of female gld/gld mice (P 
<  0.001) (Fig.  1). 
28 of the 49 gld homozygotes used in the lifespan study were autopsied when 
moribund. Seven of these had marked subcutaneous edema. At autopsy, all C3H- 
gld mice presented enlargement of all lymph nodes and splenomegaly. The liver 
and kidneys appeared normal. Anemia (HCT, <30%) or significant leukocytosis 
(>25  ×  103/mm  3) were  found in  40%  of those autopsied.  Differential  blood 
counts were determined for  14  male gld/gld  mice autopsied when moribund. 
The number of lymphocytes (18.1  ×  103/mm  3) were nearly fourfold greater and 
the number of neutrophils (5.2  ×  103/ram 3) was double that of baseline  +/+ 
control values (for comparison, see Fig. 4a and b). 
Histopathology.  All lymph nodes were massively enlarged. Histological analysis 
revealed  a  loss  of nodular  architecture  with  a  predominant  proliferation  of 
lymphocytes including an admixture of histiocytes and plasma cells (Fig. 2a-c). 
Fibrosis and muhinucleated giant cells also were frequently observed. This range 
of pleomorphism and chronic inflammatory pattern was not observed at the peak 
of primary lymphoproliferation (i.e., 20 wk old). 
To determine whether these lymphoid lesions were neoplastic, eight groups 
containing  six  young  adult  C3H-+  mice  were  inoculated  subcutaneously  or 
intraperitoneally with 20-40 mg boluses of lymph node tissue from individual 5- 
mo-old C3H-glcl donors. These recipients were examined biweekly for evidence 
of growth of the transplanted (subcutaneous or intraperitoneal) lymphoid tissue. 
No palpable growths were detected. 45 wk after transplant, all recipients were 
killed and examined for evidence of transplant growth.  None of 48  recipients 
had gross evidence of lymphoma, either spontaneous or transplanted. Although 
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FIGURE  1.  Longevity of C3H/HeJ gld and coisogenic C3H/HeJ-+ female mice. Mutant gld 
mice live only one-half as long as controls (P <  0.001). GENERALIZED  LYMPHOPROL1FERAT1VE  DISEASE  IN  MICE 
it does not appear that the gld/gld lymphoid lesion is neoplastic, the possibility 
of its being prelymphomatous has not been ruled out. 
Infiltration of lymphoid ceils into the perivascular tissue of the kidney, liver, 
salivary  glands,  pancreas,  and  other  nonlymphoid organs  was  infrequent  or 
absent.  Minor accumulations of lymphocytes in  peribronchiolar sites was seen 
rarely.  The erythroid and  myeloid components of femoral bone  marrow ap- 
peared normal  and  there  was  no  obvious  infiltration by  lymphoid cells.  The 
increase in spleen size can be attributed primarily to the expansion of the white 
pulp. 
Virtually all C3H-gld mice autopsied had an extensive inflammatory disease of 
the lung, resembling interstitial pneumonitis (Fig. 2 d-f). Typically, large num- 
bers  of well-differentiated lymphocytes and  macrophages accumulated in  the 
alveolar septa, first in the periphery and later centrally in the lobe. The alveoli 
were not collapsed. Neither alveolitis nor bronchiolitis was found. In a few cases, 
focal granulomatous reaction with giant cells was observed. Extensive necrosis 
was rare. Accumulations of eosinophils have not been observed. Analyses of the 
lungs of young adult  (8-30-wk) gld/gld mice suggested the following general 
pattern of development of pulmonary pathology: Minor focal hemorrhages and 
congestion of alveolar capillaries was followed by a moderate infiltration of the 
interstitial tissue with polymorphonuclear leukocytes (PMN). Later, macrophages 
accumulate in the alveolar septa, replacing PMN. Finally, large numbers of well- 
differentiated lymphocytes intermix with the macrophages. Perivascular infiltra- 
tion of lymphocytes was not associated with this inflammatory process. 
Histologic examination of the kidneys of moribund C3H-gld mice revealed a 
highly variable degree of change to the glomeruli and tubules. A composite score 
indicating the overall degree of lupus-like renal disease was assigned to each of 
28  cases examined. The criteria were: (-) negative, no obvious renal disease, 
(_+) minor focal glomerular change, (+) minor but multifocal glomerular change, 
(++) moderate glomerular disease, (+++) extensive glomerular disease with or 
without  tubular  pathology.  Among  the  histologic  features  considered  were 
hypercellularity, necrosis, hyalinization, capillary thickening, presence of inflam- 
matory (PMN) cells, capsular adhesions,  glomerular dilation,  tubular dilation, 
and casts. Both HE- and PAS/Schiff-stained sections were examined. Only 4 of 
28 (14%) of those kidneys from C3H-gld mice had moderate to extensive lupus- 
like disease.  The majority,  15/28  (54%),  had either none or only minor focal 
changes. 
We examined cryostat sections of kidneys from eleven gld/gld mice between 8 
and  41  wk  old  by  direct  immunofluorescence microscopy using  polyspecific 
FITC-GAMG. Significant depositions of immune complexes were found in the 
glomeruli (primarily in the mesangium) of all C3H-gld mice 22 wk old or older. 
This deposition of immune complexes is not necessarily a prelude to significant 
renal disease later in life, since the immune complex nephritis characteristic of 
the BXSB, MRL-lpr, and NZB/W lupus models is not a common feature of the 
pathology of the C3H gld mutant mouse. 
Vascular disease  including necrotizing arteritis  or polyarteritis was not  ob- 
served in our examinations of gld/gld mice. Erythema and necrosis of the ears 
and nuchal dermatitis so common in MRL lpr mice is not observed in C3H-gld ROTHS,  MURPHY,  AND  EICHER 
FIGURE 2.  Histopathology  of C3H/HeJ-gld  mice. Hematoxylin and eosin. (a-c) Lymph node. 
(a)  22-wk-old  gld/gld  male.  Lymph  node  is greatly enlarged with  diffuse proliferation of 
lymphoid cells with loss of normal architecture. Clusters of lymphoid cells are often observed 
(x 27).  (b) Higher magnification (x 270) showing the predominance of mature lymphocytes 
and immunoblasts. (c) 63-wk-old gld/gld male (x 270).  The cellularity of the enlarged lymph 
nodes is pleomorphic, with macrophages, plasma cells, and foreign body giant cells (arrow) in 
evidence. Moderate fibrosis is often observed. Sinusoids may be engorged with blood. (d-f) 
Lung from 63-wk-old gld/gld male. (d) Low magnification (x 27) showing extensive interstitial 
inflammatory disease. There is no bronchiolitis  and alveolitis.  (e) Higher magnification (x 270). 
The  earliest changes  are  capillary engorgement  and  infiltration of the  interstitium  with 
polymorphonuclear leukocytes. (f) More advanced lesions usually consist of extensive accu- 
mulations of macrophages (arrows) and well-differentiated lymphocytes (x 270).  PMN have 
been replaced. Focal hemorrhage as well as granulomatous lesions with foreign body giant 
cells (not shown) are common at this age. 8  GENERALIZED LYMPHOPROLIFERATIVE DISEASE IN  MICE 
mice. 
Chronology of Lymphoproliferation.  The weights of the mesenteric node com- 
plex, left and right axillary, left and right renal, and the lumbar/caudal lymph 
nodes from individual mice were added and presented as the "combined lymph 
node weight" (Fig. 3). By 8 wk of age, a significant increase in lymph node weight 
was found for both male (76 mg, P  <  0.05) and female (66 rag, P  <  0.001) gld 
homozygotes compared  with  normal  male  (53  rag)  or  female  (45  rag)  +/+ 
controls. By 12 wk of age, the lymph nodes of male C3H-gld mice were ninefold 
heavier than  those of controls.  By  20  wk,  they reached 2,530  mg,  a  60-fold 
increase compared with +/+ controls. A major regression of lymph node mass 
(originally observed during periodic palpation of mice held for lifespan studies) 
was evident from this cross-sectional analysis.  By 30  wk of age, male C3H-gld 
mice had a combined lymph node weight of 1,050 mg, a significant reduction (P 
<  0.005)  of 1,500  mg compared with the weight  10  wk earlier (the peak of 
primary lymphoproliferation). A  significant rebound was evident by 38  wk of 
age, with lymph node weights increasing by 820 mg from the 30-wk-old low (P 
<  0.025).  The increase in lymph node mass reached nearly 3,000  mg (96-fold 
increase over age-matched male controls) by 47  wk.  There was no significant 
difference in  the lymph node weight of female as compared with male gld/gld 
mice at any age evaluated (8,  16, 24, and 47 wk). 
Significant splenic enlargement was evident as early as  12 wk of age in male 
(P <  0.005)gld/gld mice (Fig. 3). At 16 wk of age, gld/gld females and males had 
2.9- and 4.1-fold increases over their respective controls. By 47 wk, the spleens 
of gld males were 7.5-fold heavier than controls. The most accelerated phase of 
splenic enlargement occurred between 38 and 47 wk of age. Unlike the lymph 
node mass, the spleen did not undergo a pronounced episode of enlargement- 
regression-rebound (Fig. 3). 
There  was no  significant difference at  any age tested between the thymus 
weights ofgld/gld mutant mice and of age- and sex-matched +/+ controls. There 
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FIGURE 3.  Changes in lymph node (  ) and spleen (---) weight with age in C3H-gtd  (0) 
and C3H-+ ((3) male mice. Lympb node weight represents the summation of mesenteric, 
axillary, renal, and the lumbar/caudal  lymph  nodes. Five or six mice were used for each age 
point. Several  stages of the gld lymphoproliferative  process can be identified:  preproliferative 
(<8 wk), primary  proliferative  (12-20 wk), regressive  (20-30 wk),  and a secondary  proliferative 
phase (30-47 wk). ROTHS,  MURPHY,  AND  EICHER 
was no significant  difference at any age in body weight between genotypes of 
either sex. 
Hematology.  Hematologic evaluations were conducted on C3H-gld male mice 
at 4-wk intervals from 4- to 24 wk of age and also at 30, 38, and 47 wk of age. 
The total leukocyte count of male gld/gld mice rose from 7.1  ×  10S/mm 3 at 4 
wk to a maximum of 25.4 ×  10s/ram 3 at 24 wk of age. At 47 wk, this leukocytosis 
was reduced  to  15.2  ×  103/mm 3.  The  total  leukocyte counts of 20 male  +/+ 
mice ranging in age from 8 to 47 wk was 8.0 __. 0.4 ×  103/mm 3. 
The  number  of circulating  lymphocytes rose dramatically,  reaching  19.1  × 
103/mm 3 at 24 wk of age (Fig. 4 a). The change with age in numbers of circulating 
lymphocytes corresponds closely with changes in lymph node weight. The regres- 
sion in  lymph  node mass is paralleled  by a  significant  reduction  of circulating 
lymphocytes, from  19.1  to 9.9  ×  103 cells/ram 3, between 24 and 30 wk of age 
(P <  0.01).  Microscopically, the majority of lymphocytes were small well-differ- 
entiated cells.  Male C3H-+ control mice had an average of 5.0 +  0.34  ×  103/ 
mm 3 lymphocytes at  12-47 wk of age. The number of circulating iymphocytes 
in male C3H gld mice was significantly greater (P <  0.005) than in controls  16 
wk of age and older. The number of neutrophils  was significantly greater (two 
to threefold) in male gld/gld compared with +/+ mice, from 8 to 38 wk old (Fig. 
4b). Immature polymorphonuclear forms were uncommon. 
At  47  wk the  number  of circulating  erythrocytes had  decreased  to  88%  of 
normal  in  both sexes.  Packed cell volumes were similarly  reduced to -93% of 
normal in both sexes. This modest normocytic anemia was not observed during 
the peak of primary lymphoproliferation (20 wk). 
Lymphocyte Subsets.  24 gld/gld males between 8 and 39 wk old were killed and 
mesenteric  lymph  nodes  were  removed  for  immunofluorescence  analysis  to 
determine the frequency and numbers of surface Ig (sIg)-positive (B cells), Thy- 
1-positive  (T  cells),  and  sIg-  and  Thy-l-negative  (null)  lymphoid  cells.  The 
mesenteric lymph nodes of 19 adult (8-39 wk old) +/+ males were included in 
this  study.  At  18-24  wk of age,  there was a  significant  increase above normal 
(+/+) in the absolute number of all three lymphoid subsets for this population 
of gld homozygotes. The frequency of B cells decreased from 31.3 to  14.3 %; T 
cells increased from 61.5 to 67.9%; and null cells increased from 7.1  to  17.8%. 
The number of viable cells obtained from the mesenteric node complex of C3H- 
gld  mice  was  331 '×  106  compared  with  26  ×  10 6  for  C3H-+  controls.  By 
extrapolation, absolute numbers of B, T, and null lymphocytes in gld/gld (com- 
pared with +/+) mice increased by 6-,  15-, and 33-fold, respectively (Table II). 
FMF analysis of age-matched pairs of mutant and control lymphocyte suspen- 
sions confirmed the observations made by fluorescence microscopy. Typically, 
FMF produced  histograms  that  confirmed  the  decreased  frequency of B  cells 
and the increase in frequency of T  cells and null cells (Fig. 5a and b). 
Serum Proteins and Immunoglobulin.  The amount of total serum protein  was 
similar for gld/gld and  +/+  mice.  18 male gld[gld mice between  18 and 24 wk 
old had 7.01  4-_ 0.13 g protein/dl of serum compared with 7.06 _  0.08 g for 14 
adult +/+ male controls. 
Electrophoretic analysis of serum revealed a  prominent  increase with age of 
gamma  region proteins from gld homozygotes. The  sera of 34 gld/gld and  10 10  GENERALIZED  LYMPHOPROLIFERATIVE DISEASE IN  MICE 
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FIGURE 4.  Peripheral leukocyte counts in C3H gld (  ) and normal (- --) male mice. Mean 
numbers of leukocytes _+ SE from groups of five or six gld/gld mice (46 total). Because the 
numbers of each cell type remained constant in control mice (8-47 wk old), the data was 
pooled  (n  =  20). (a)  Lymphocytes.  The fluctuation in numbers of lymphocytes with  age 
recapitulates the changes in lymph node mass with age (see Fig. 3). (b) Neutrophils. There was 
a significant increase in the number of peripheral blood neutrophils (two to threefold)  in gld/ 
gld mice compared with controls at all ages examined (8-38 wk). 
TABLE  II 
Analysis of the Major Lymphocyte Subsets in C3H-gld Male Mice 
Sum-  Age 
Genotype  (weeks)  ber of 
mice 
Numbers of mesenteric lymph node cells (X 10  6) 
All cells  B cells*  T cells*  Null cells  ~ 
+/+  8-39  19  25.2 -  2.31  7.9 ± 0,8  15.5 ±  1.6  1.8 _ 0.2 
gld]gld  8-9  8  37.1 + 5.0  9.2 ±  1.5  23.7 ± 3.4  4.2 ± 0.9 
gld/gld  18-24  9  330.8 ± 39.4  47.3 ± 4.8  224.6 ± 28.5  58.9 ±  12.2 
gld/gld  33-39  7  87.7 ±  16.2  16.2 ± 3.5  53.7 ± 8.8  17.8 ± 5.2 
*  slg-positive. 
* Thy-1 alloantigen-positive. 
0 slg- and Thy-l-negative. 
! All values are expressed as mean + SE. 
+/+  males  were  examined  by  cellulose  acetate  electrophoresis.  The  gamma 
region proteins ofgld/gtd  mice rose from 2.3% at 4-8 wk of age to 8.8% at 20- 
24 wk and  17% at 38-47  wk.  None of the sera of C3H-+ mice (24-47 wk old) 
had gamma globulin in excess of 3% of total protein. Analysis of densitometric 
traces  indicates  that  the  sera  of  clinically affected  gld/gld  mice  have  either 
electrophoretically broad or restricted gammopathies (Fig. 6a-d).  All of 13 sera ROTHS,  MURPHY,  AND  EICHER  11 
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FIGURE 5.  Fluorescence distribution of mesenteric lymph node cells stained for (a) slg alone, 
B lymphocytes, and (b) both Thy-1 and sIg, T and B lymphocytes, from 24-wk-old mutant gld/ 
gld (---) and +/+ (  ) female mice. Percentages indicate the frequency of positive cells that 
met or exceeded the criteria of fluorescence intensity, channel 58 (50,000 cells  analyzed). 
Mutant gld mice have a reduced frequency of B cells (14%) compared with controls (43%). 
Null cells (Thy-l-, sIg-) increase from 7% in control mice to 21% in C3H-gld mice. 
from 20-24-wk-old gld/gld mice had broad migration of gamma region proteins 
similar to that in Fig. 6b. At 30-47 wk of age, one-half (8/16) of the sera tested 
from C3H-gld mice had  electrophoretically restricted gammapathy similar to 
that in Fig. 6c. The majority of these sera had elevations of "slow" rather than 
"fast" (cathodic migration) gamma proteins. A few sera had bimodal distribution, 
as seen in Fig. 6 d. Increases in beta globulin were not remarkable. None of the 
sera  from  clinically affected gld/gld mice had  significant alterations  of alpha 
region globulin. 
All classes of immunoglobulin measured by RID were markedly elevated in 
20-24-wk-old C3H-gld mice compared with age-matched controls (Fig.  7). The 
mean serum Ig levels (mg/ml) for eight C3H-+ mice were: IgA, 0.21  +  0.01; 
IgG1, 0.67  4- 0.05;  IgG2a,  1.25 4- 0.32; IgG2b, 0.19 4- 0.04; and IgM, 0.36  4- 
0.02. All of 10 sera from C3H-gld  mice had at least a threefold increase in serum 
IgM. The proportion of C3H-gld mice with at least fivefold elevations in serum 
IgG1, IgG2b,  IgA, and IgG2a were 30, 60,  70, and 80%, respectively. 9 of 10 
clinically affected gld homozygotes had major increases in  more than one im- 
munoglobulin isotype. There appeared to be a  mutually exclusive relationship 
between elevations of the IgA and IgG1 isotypes. The sera with the five highest 
IgA levels had low level IgG1. The three highest IgG1 levels corresponded with 
low level IgA (data not shown). 12  GENERALIZED  LYMPHOPROLIFERAT1VE  DISEASE  IN  MICE 
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FIGURE 6.  Cellulose acetate electrophoresis of serum from normal +/+ (a) and selected cases 
of mutant gld/gld (b-d) mice. An increase in gamma (3') region proteins (vertical hatching) is 
found  in  nearly  all  clinically affected gld  mice.  ALB,  albumin;  c~,  alpha globulin; /3,  beta 
globulin. 
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FIGURE 7.  Quantitation of the major serum immunoglobulin classes by RID.  In a  number 
of cases, the level of serum lg exceeded the working limits of the system (as defined by the 
supplier). Rather than extrapolate beyond these limits, those individual high values are shown 
above a  horizontal dashed bar indicating the appropriate upper limit. All C3H-gld mice had 
marked elevations of two or more Ig classes. ROTHS,  MURPHY,  AND  E1CHER  13 
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FIGURE 8.  Frequency  of  ANA  positivity  with  age  (indirect  immunofluorescence  assay). 
Cryostat sections of rat liver were incubated with 1:10 diluted sera from mutant gld (  ) and 
control (---)  mice followed by exposure to FITC-labeled RAMG. Sera from five or six males 
were examined at each age indicated.  Additionally, sera from eight gld/gld and six control 
females, 24-wk-old, were evaluated. 
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FICURE  9.  Frequency of anti-dsDNA autoantibody positivity. C. luciliae kinetoplast fluores- 
cence determined after incubation with  1:10 diluted serum  followed by  FITC-GAMG.  (a) 
Number of positive sera/number of examined sera. (b) Includes sera from four female C3H- 
gld or four female C3H-+ mice. (c) +/+ refers to the wild-type allele at both the gld and lpr 
loci. 
Antinuclear Autoantibody.  Autoantibodies  directed  against  nuclear  antigens 
were detected in sera from C3H-gld mice. Sera from all of the male gld/gld and 
+/+ mice killed at monthly/bimonthy intervals were evaluated for ANA. By 8 
wk of age, two of the  five gld/gld sera (diluted  1  : 10) assayed were positive for 
ANA (Fig. 8). Beginning at  16 wk of age, all of 40 sera from C3H-gld mice were 
positive. None of the sera from C3H-+ mice from 8 to 47 wk were positive. Sera 
from eight 24-wk-old C3H-gld mice were twofold serially diluted from  1:50 to 
1:1,600.  Five of eight  of these  sera  had  positive ANA activity at  dilutions  of 
1:400. 
Anti-dsDNA Autoantibody.  Using  the  kinetoplast  of C.  luciliae as  a  dsDNA 
target in immunofluorescence studies, we found that serum of C3H-gld mice had 
levels of anti-dsDNA autoantibody similar to or exceeding that of other murine 14  GENERALIZED  LYMPHOPROLIFERATIVE  DISEASE  IN  MICE 
models known to have high levels of this antibody (Fig. 9). All of 19 sera (diluted 
1:10)  from 12-24-wk-old C3H-gld mice were positive for anti-dsDNA autoanti- 
body. All eight sera from mice homozygous for the lpr mutation and ~65%  of 
sera from strain BXSB and NZB male mice also were positive for anti-dsDNA. 
None of the sera from 19 congeneic normal C3H-+/+,  15 C57BL/6, or 6 SJL/ 
J  nonautoimmune mice had anti-dsDNA activity. 
Thymocyte-binding  Autoantibody.  The sera of C3H-gld mice contain significant 
levels of autoantibody to  cell surface determinants expressed on young adult 
thymocytes. Autoantibody was detected on  >50%  of target thymocytes after 
incubation with  1:2  diluted sera from 20  wk or older gld/gld mice. Sera from 
congeneic +/+ control (from 4 to 47 wk old) mice had an average of 7% positive 
target thymocytes in this immunofluorescence assay (Table III). Approximately 
50% of thymocytes were positive after incubation with sera from 1-yr-old NZB 
mice. Sera from clinically affected MRL-lpr mice or young adult C57BL/6J mice 
had negligible levels of TBA. 
Discussion 
The autosomal recessive mutation gld (generalized lymphoproliferative disease) 
induces  the  development  of massive,  early  onset  lymphoid  hyperplasia  with 
hyperimmunoglobulinemia and production  of autoantibodies to  native  DNA. 
These basic elements of the gld phenotype resemble those of the disease induced 
by another autosomal mutation, lpr (lymphoproliferation) (16, 17). In this paper, 
we demonstrate that Ipr and gld are not allelic.  Linkage studies place gld on 
TABLE  III 
Thymocyte-binding Autoantibody in C3H-gld/gld Mice* 
Geno-  Age in weeks 
Strain  Sex 
type  4-8  12  16  20  24  30-38  47 
C3H  gld/gld  Male  2.3*  10.2  24.4  58.9  52.6  °  57.8  77.2 
+1,9  4-1.9  +5.9  4-9.2  4-7.2  4-10.5  4-3.1 
(6)  (5)  (5)  (5)  (14)  (1 O)  (6) 
C3H  +/+1  Male  6.1  9.2  5.3  6.6 
4-2.2  4-2.8  4-1.2  4-3.1 
(5)  (5)  (9)  (5) 
P:~ NS  <0.05  <0.001  <0.001 
NZB  +/+  Male and  47.1 
female  _+ 14.0 
(6) 
MRL  lpr/lpr  Female 
C57BL/6  +/+  Male and  2.3 
female  +1,0 
7.t 
4-0.9 
(6) 
* The  degree  of TBA  is  indicated  by  the  percentage  of target  thymocytes from  young  adult 
C3H-+/+ mice that were fluorescence positive after incubation with 1:2 diluted serum and FITC- 
GAMG. Anti-Thy-l.2 aUoantisera gave >96% positive target thymocytes. 
* Values are expressed as mean percent 4- SE.  Numbers of sera tested are in parentheses. 
0 One-half of the serum samples from 24-wk-old gld/gld and +/+ mice were from female donors. 
I  +/+ refers to wild-type allele (normal) at both the gld and lpr loci. 
Probability determined by Student's t test for independent means. NS, not significant at P <  0.05. ROTHS,  MURPHY,  AND  EICHER  15 
chromosome 1 between the Pep-3  and Lp loci. The chromosomal location of the 
lpr mutation is not known. 
Beyond  these  basic  similarities,  C3H-gld and  MRL-lpr mice  have  several 
fundamental differences: (a) C3H-gld mice have an extended postproliferative 
clinical course with an episode of regression of lymph node mass and survival 
extending to  1 yr of age.  (b) C3H-gld mice have a  substantial increase in the 
frequency of Thy-l-negative and sIg-negative (null) ceils in their lymph nodes. 
(c)  At  the  peak  of primary  lymphoproliferation, C3H-gld mice  have  major 
increases (>13-fold) of serum IgA and IgG2b. (d) Histologically, C3H-gld mice 
are essentially free of the profound perivascular lymphoid infiltrates routinely 
observed in the kidney, liver, and other organs of MRL-lpr mice. (e) In C3H-gld 
mice, the renal glomerulus and tubular apparatus is essentially normal at the age 
when  MRL-lpr mice  are  dying  with  subacute  immune complex  glomerulo- 
nephritis (i.e., 4-6  mo). (f) Vascular disease, such as necrotizing arteritis and 
polyarteritis, seen commonly in MRL-lpr  mice, is not found in C3H-gld  mice. (g) 
C3H-gld mice  develop moderately high levels of TBA  by  20  wk of age.  In 
contrast, MRL-lpr mice are essentially negative. (h) C3H-gld mice consistently 
develop an interstitial pneumonitis without major perivascular lymphoid infiltra- 
tions. 
The  need  for  animal  models of spontaneous respiratory  diseases,  such  as 
chronic  interstitial  pneumonitis (including  hypersensitivity pneumonitis), has 
been discussed by Reid (30). Several distinct pulmonary diseases in man associated 
with aberrant immune functions, including autoimmunity, have been reviewed 
by Schatz et al. (31).  Among these disorders are lymphocytic interstitial pneu- 
monitis (often with coexistent Sj6gren's syndrome) (32), immunoblastic lymph- 
adenopathy (33), idiopathic interstitial pneumonitis with immune complexes (34), 
and lupus pneumonitis (35). 
Interstitial lung disease has been experimentally induced in laboratory animals 
using both allogeneic soluble lung antigen (in strain C3H/He) (36) and preformed 
immune complexes  (37).  In  addition  to  the  severe  chronic  lupus  nephritis 
characteristic  of (NZB  ×  NZW)FI  hybrid,  Eisenberg et  al.  (38)  identified a 
coexistent pulmonary interstitial disease that  was  considered immunologic in 
origin. Preliminary studies of lungs from C3H-gld mice have not implicated an 
extrinsic microbial factor. Serological studies have not detected an antiglomer- 
ular basement membrane-like factor by immunofluorescence. Direct immunoflu- 
orescence studies do not indicate significant immune complex (IC) deposition. 
In view of the above and the absence of damage to other tissues usually associated 
with IC disease (membranous glomerulonephritis, vasculitis),  mutant gld mice 
may be useful in studies that explore alternative mechanisms of immunologically 
mediated pulmonary disease. 
Genetic  interactions may have  a  major  influence on  the pathogenesis and 
clinical course ofgld-  and lpr-induced  autoimmune diseases. We have successfully 
transferred the mutant gene lpr to  strain  C3H/HeJ  by multiple (>10)  cross- 
intercross matings.  Although MRL-lpr and C3H-lpr mice have  similar latent 
periods and degree of generalized lymphadenopathy, the longevitities oflpr mice 
on these two backgrounds are markedly different: the average lifespan of MRL- 
lpr is  5  mo  compared  with  11  mo  for  C3H-lpr mice.  Thus,  the  genomic 16  GENERALIZED LYMPHOPROLIFERAT1VE DISEASE IN  MICE 
background  may have a  significant effect on  the expression of other mutant 
genes (such as gld) that affect the regulation of the immunologic apparatus. To 
evaluate more precisely the specificity of gld-determined  immune aberrations 
(compared with Ipr), we have developed gld and lpr congeneic lines sharing the 
common inbred backgrounds C3H/HeJ, C57BL/6J, and SJL/J. 
The defective lipopolysaccharide response gene (Lps) present in strain C3H/ 
HeJ (39) may have a specific influence on the expression of gld (as well as lpr). 
Both the gld and lpr mutant genes have been transferred to the closely related 
non-Lps-bearing  (normal) strain  C3HeB]FeJ.  Parallel  populations  of homozy- 
gous gld mice with and without the Lps mutation are currently being followed in 
lifespan  studies.  Izui  et al.  (40)  have  demonstrated that  the  injection  of the 
polyclonal B  cell activator  bacterial  lipopolysaccharide is able  to  induce anti- 
DNA antibodies in most inbred strains of mice, including C3HeB/FeJ but not 
C3H/HeJ.  We  have determined that  young adult C3H/HeJ-gld  mice sponta- 
neously produce high titers of anti-dsDNA antibody. Spontaneous polyclonal B 
cell activation (PBA) is a characteristic of mice with autoimmune disorders, such 
as Palmerston North (PN), NZB, (NZB ×  NZW)FI, MRL lpr, and male BXSB, 
but not of mice from other, "normal" inbred strains (41, 42). The new mutant 
gene, gld, on  inbred  background  C3H/HeJ,  may be  of value in  determining 
whether PBA is a critical factor in the pathogenesis of spontaneous autoimmunity. 
In view of the extreme hyperactive state of the B cell system in C3H-gld mice, 
one of the most intriguing findings in this study was the relative lack of significant 
damage to tissues that are commonly affected in  IC disease, such as the renal 
glomerulus and blood vessels.  The lack of cellular infiltrates in such organs as 
the  kidney, liver,  salivary glands,  and  pancreas  is  unique  in  comparison  with 
other spontaneous  murine models.  The  immunobiology of IC  formation and 
subsequent events, including tissue  deposition  and  reactivity of the host,  is  a 
complex process (43) that may become more fully understood in studies of C3H- 
gld mice. 
In addition to their value in pathologic studies at the tissue level, single-gene 
mutations causing autoimmune, lymphoproliferative, and immunodeficiency  dis- 
orders have been of value in studies of immunoregulatory networks (44).  Defi- 
ciencies relating to the T  cell regulatory lymphokine, interleukin 2 (IL-2), have 
recently been identified in lpr mutant mice (45, 46). It is generally accepted that 
normal cellular interactions depend in large part on the recognition of molecules 
expressed at  the cell surface.  Recently, the lymphocyte cell surface of lpr/lpr 
mice has been the focus of several studies. The uniqueness of the hyperplastic 
lymphoid cell has been defined by classic and novel antisera directed against cell 
surface antigens (19, 24), as well as a variety of lectins (20). In the present study, 
at  the peak  of primary lymphoproliferation (18-24  wk),  the  lymph nodes of 
C3H-gld mice had increased numbers of B cells (sixfold), T  cells (15-fold), and a 
dramatic  expansion  (33-fold)  of null  (sIg-,  Thy-1-)  lymphocytes. A  detailed 
examination of the  lymphocyte surface phenotype, lymphocyte function, and 
production  of and  response  to  lymphokines,  such as  IL-2,  will  be  critical  to 
understand the pathogenesis of this disorder induced by the gld mutation. 
It is becoming increasingly clear that the cellular basis for lupus is different 
among the major inbred and single-factor murine models (11, 12). To determine ROTHS, MURPHY, AND  EICHER  17 
the basic mechanisms leading to autoimmunity and consequential immunologic 
disease(s), the ability to isolate the genetic, viral, and environmental components 
is critical. Coisogenic and congeneic inbred strains differing at a single locus or 
chromosomal segment provide a powerful tool for studies of complex processes 
at the molecular level. The ability to manipulate Mendelian genes such as gld, 
on multiple inbred strain backgrounds or in combination with other mutations 
with known immune aberrations, such as bg, hr, Lps, nu, and xid (47), may enable 
us to dissect the factors involved in the regulation of normal immune responses 
and to  define the common denominators in  the pathogenesis of autoimmune 
diseases. 
Summary 
A newly discovered autosomal recessive mutation, generalized/ymphoprolifer- 
ative disease (gld), in the C3H/HeJ strain of mice, determines the development 
of early  onset  massive  lymphoid  hyperplasia  with  autoimmunity.  Significant 
lymph node enlargement is apparent as early as 12 wk of age. By 20 wk, lymph 
nodes are 50-fold heavier than those of coisogenic C3H/HeJ-+/+ mice. There 
is  a  concomitant  increase  in  the  numbers  of peripheral  blood  lymphocytes. 
Analysis of C3H-gld  lymph node  lymphocyte subsets  by  immunofluorescence 
indicates an  increase in  numbers  of B  cells,  T  cells,  and  null  (Thy-l-,  sIg-) 
lymphocytes by  6-,  15-,  and  33-fold  compared with  congeneic control  mice. 
Serologically,  gld/gld  mice  develop  antinuclear  antibodies  (including  anti- 
dsDNA), thymocyte-binding autoantibody, and hypergammaglobulinemia with 
major increases in several immunogiobulin isotypes. Mutant gld mice live only 
one-half as  long as normal  controls (12  and  23  mo; respectively). Interstitial 
pneumonitis was found in virtually all C3H-gld mice autopsied when moribund. 
Although immune complexes were detected in the glomerulus by immunofluo- 
rescence techniques, only 14%  of the autopsied mice had significant lupus-like 
nephritis. Vascular disease was not found. 
The pattern  of early onset massive lymph node enlargement, hypergamma- 
globulinemia, and production of antinuclear autoantibodies resembles the basic 
abnormal  phenotype induced by the Ipr (lymphoproliferation) mutation.  The 
mutations gld and lpr are not allelic. Linkage studies indicate that gld is located 
between Pep-3 and Lp on chromosome 1. 
This new mutation adds another genetically well-defined model to the list of 
routine lymphoproliferative/autoimmune  disorders that may be exploited to gain 
a clearer understanding of immunoregulatory defects and for identifying com- 
mon pathogenetic factors involved in systemic autoimmune diseases. 
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